Item 5.02.....Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.




On October 26, 2020, Masimo Corporation ("Masimo") appointed J. Todd Koning, age
48, as its Chief Accounting Officer. In this role, Mr. Koning will act as
Masimo's principal accounting officer.
J. Todd Koning has served as Masimo's Senior Vice President of Financial
Planning and Analysis since April 2018. From March 2016 to March 2018, Mr.
Koning served as Vice President of International Finance for NuVasive, Inc.
(Nasdaq: NUVA), a medical device company focused on the design, development and
marketing of products for the surgical treatment of spine disorders. Prior to
that time, from March 2014 to February 2016, he served as Vice President of
Finance and Human Resources with Ellipse Technologies, a medical device company
acquired by NuVasive in 2016. From May 2001 to March 2014, Mr. Koning served in
various finance and accounting roles with Boston Scientific and Guidant
Corporation, which was acquired by Boston Scientific in 2006. Mr. Koning
received a B.S. in Engineering from Michigan State University and an M.B.A. from
Purdue University.
In connection with Mr. Koning's appointment as Masimo's Chief Accounting
Officer, Masimo did not: (1) enter into any material plan, contract or
arrangement with Mr. Koning, (2) enter into any material amendment of any plan,
contract or arrangement to which Mr. Koning was a party prior to his appointment
as Masimo's Chief Accounting Officer, or (3) grant any award or modify any award
granted to Mr. Koning prior to his appointment as Masimo's Chief Accounting
Officer. Masimo has also entered into Masimo's standard form Indemnity Agreement
with Mr. Koning.
Mr. Koning does not have any family relationship with any director or executive
officer of Masimo and has not been directly or indirectly involved in any
transactions with Masimo. Mr. Koning was not selected to serve as Masimo's Chief
Accounting Officer pursuant to any arrangement or understanding with any person.
Item 9.01.     Financial Statements and Exhibits.

(d) The following items are filed as exhibits to the Current Report on Form 8-K.


    Exhibit
      No.       Description
      104       Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses